KALA BIO, Inc.
KALA • NASDAQ • Stock Fundamentals
KALA BIO, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Avi Minkowitz, with a market cap of $45.9M.
Market Cap$45.9M
Employees43.0
CEOAvi Minkowitz
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsMay 15, 2026 · 29 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
KALA BIO, Inc. FAQ
Common questions about KALA BIO, Inc.
KALA BIO, Inc. (KALA) has a market capitalization of $45.9M and trades on NASDAQ.
KALA BIO, Inc. has approximately 43 employees.